The ethics of human embryos and embryonic stem cell research

Journal of Stem Cells

Volumn 3, Issue 2, 2008, Pages 127-131

  Master, Zubin ^a   Laforce, Daisy ^b   McLeod, Marcus ^c   Williams Jones, Bryn ^d  

^a CARLETON UNIVERSITY   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; DIETHYLSTILBESTROL; GONADOTROPIN;

ARTIFICIAL INSEMINATION; CANCER RESEARCH; CELL CLONING; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; COMMERCIAL PHENOMENA; CONFLICT OF INTEREST; CYTOLOGY; DEVELOPMENTAL BIOLOGY; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EMBRYOTOXICITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC DISORDER; GRAFT REJECTION; HEALTH HAZARD; HUMAN; HUMAN DIGNITY; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL LITERATURE; MORALITY; NONHUMAN; OOCYTE DONATION; OVARY CANCER; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PATENT; PLURIPOTENT STEM CELL; RESEARCH ETHICS; REVIEW; RISK BENEFIT ANALYSIS; SOCIAL ASPECT; SOMATIC CELL; STEM CELL TRANSPLANTATION; SURGICAL RISK; TOXICITY TESTING;

EID: 77953655043     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (253)

1. Evans, M.J. and Kaufman, M.H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154-156.
2. Martin, G.R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U S. A, 78, 7634-7638.
3. Deacon, T., Dinsmore, J., Costantini, L.C., Ratliff, J., and Isacson, O. (1998) Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp. Neurol., 149, 28-41.
4. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergie I,J.J., Marshall, V.S., and Jones, J.M. (1998) Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147.
5. Pedersen, R.A. (2002) Feeding hungry stem cells. Nat. Biotechnol., 20, 882-883.
6. Richards, M., Fong, C.Y., Chan, W.K., Wong, P.C., and Bongso, A. (2002) Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol., 20, 933-936.
7. Hovatta, O., Mikkola, M., Gertow, K., Stromberg, A.M., Inzunza, J., Hreinsson, J., Rozell, B., Blennow, E., Andang, M., and Ahrlund-Richter, L. (2003) A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum. Reprod., 18, 1404-1409.
8. Keller, G.M. (1995) In vitro differentiation of embryonic stem cells. Curr. Opin. Cell Biol., 7, 862-869.
9. Smith, A.G. (2001) Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol., 17, 435-462.
10. Smith, D.A., Glover, J.L., Townsend, L.E., and Maupin, D.E. (1991) A method for the harvest, culture, and characterization of human adult atrial myocardial cells: correlation with age of donor. In Vitro Cell Dev. Biol., 27A, 914-920.
11. Wiles, M.V. and Johansson, B.M. (1999) Embryonic stem cell development in a chemically defined medium. Exp. Cell Res., 247, 241-248.
12. Bradley, A., Evans, M., Kaufman, M.H., and Robertson, E. (1984) Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature, 309, 255-256.
13. Smith, A.G., Heath, J.K., Donaldson, D.D., Wong, G.G., Moreau, J., Stahl, M., and Rogers, D. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature, 336, 688-690.
14. Rossant, J. (2001) Stem cells from the Mammalian blastocyst. Stem Cells, 19, 477-482.
15. Pain, B., Clark, M.E., Shen, M., Nakazawa, H., Sakurai, M., Samarut, J., and Etches, R.J. (1996) Long-term in vitro culture and characterisation of avian embryonic stem cells with multiple morphogenetic potentialities. Development, 122, 2339-2348.
16. Doetschman, T., Williams, P., and Maeda, N. (1988) Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Dev. Biol., 127, 224-227.
17. Wheeler, M.B. (1994) Development and validation of swine embryonic stem cells: a review. Reprod. Fertil. Dev., 6, 563-568.
18. Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., Becker, R.A., and Hearn, J.P. (1995) Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. U. S. A, 92, 7844-7848.
19. Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., and Hearn, J.P. (1996) Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol. Reprod., 55, 254-259.
20. Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A., and Bongso, A. (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol., 18, 399-404.
21. Lanzendorf, S.E., Boyd, C.A., Wright, D.L., Muasher, S., Oehninger, S., and Hodgen, G.D. (2001) Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. Fertil. Steril., 76, 132-137.
22. Mitalipova, M., Calhoun, J., Shin, S., Wininger, D., Schulz, T., Noggle, S., Venable, A., Lyons, I., Robins, A., and Stice, S. (2003) Human embryonic stem cell lines derived from discarded embryos. Stem Cells, 21, 521-526.
23. Park, J.H., Kim, S.J., Oh, E.J., Moon, S.Y., Roh, S.I., Kim, C.G., and Yoon, H.S. (2003) Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biol. Reprod., 69, 2007-2014.
24. Pickering, S.J., Braude, P.R., Patel, M., Burns, C.J., Trussler, J., Bolton, V., and Minger, S. (2003) Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. Reprod. Biomed. Online., 7, 353-364.
25. Cowan, C.A., Klimanskaya, I., McMahon, J., Atienza, J., Witmyer, J., Zucker, J.P., Wang, S., Morton, C.C., McMahon, A.P., Powers, D., and Melton, D.A. (2004) Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med., 350, 1353-1356.
26. Stojkovic, M., Lako, M., Stojkovic, P., Stewart, R., Przyborski, S., Armstrong, L., Evans, J., Herbert, M., Hyslop, L., Ahmad, S., Murdoch, A., and Strachan, T. (2004) Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells, 22, 790-797.
27. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
28. Betts, D.H. and King, W.A. (1999) Telomerase activity and telomere detection during early bovine development. Dev. Genet., 25, 397-403.
29. Brenner, C.A., Wolny, Y.M., Adler, R.R., and Cohen, J. (1999) Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos. Mol. Hum. Reprod., 5, 845-850.
30. Thomson, J.A. and Marshall, V.S. (1998) Primate embryonic stem cells. Curr. Top. Dev. Biol., 38, 133-165.
31. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res., 25, 585-621.
32. Allsopp, R.C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E.V., Futcher, A.B., Greider, C.W., and Harley, C.B. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U. S. A, 89, 10114-10118.
33. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11, 1921-1929.
34. Strelchenko, N., Verlinsky, O., Kukharenko, V., and Verlinsky, Y. (2004) Morula-derived human embryonic stem cells. Reprod. Biomed. Online., 9, 623-629.
35. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., and Yamanaka, S. (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 113, 631-642.
36. Chambers, I., Colby, D., Robertson,M., Nichols, J., Lee, S., Tweedie, S., and Smith, A. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell, 113, 643-655.
37. Wiles, M.V. and Keller, G. (1991) Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development, 111, 259-267.
38. Li, M., Pevny, L., Lovell-Badge, R., and Smith, A. (1998) Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol., 8, 971-974.
39. Dani, C., Smith, A.G., Dessolin, S., Leroy, P., Staccini, L., Villageois, P., Darimont, C., and Ailhaud, G. (1997) Differentiation of embryonic stem cells into adipocytes in vitro. J. Cell Sci., 110 (Pt 11), 1279-1285.
40. Rohwedel, J., Maltsev, V., Bober, E., Arnold, H.H., Hescheler, J., and Wobus, A.M. (1994) Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev. Biol., 164, 87-101.
41. Klug, M.G., Soonpaa,M.H., Koh, G.Y., and Field, L.J. (1996) Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest, 98, 216-224.
42. Kramer, J., Hegert, C., Guan, K., Wobus, A.M., Muller, P.K., and Rohwedel, J. (2000) Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech. Dev., 92, 193-205.
43. Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., and McKay, R. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292, 1389-1394.
44. Surani, M.A. and Barton, S.C. (1983) Development of gynogenetic eggs in the mouse: implications for parthenogenetic embryos. Science, 222, 1034-1036.
45. Hagemann, L.J., Peterson, A.J., Weilert, L.L., Lee, R.S., and Tervit, H.R. (1998) In vitro and early in vivo development of sheep gynogenones and putative androgenones. Mol. Reprod. Dev., 50, 154-162.
46. Ozil, J.P. and Huneau, D. (2001) Activation of rabbit oocytes: the impact of the Ca2+ signal regime on development. Development, 128, 917-928.
47. Carroll, J. (2001) The initiation and regulation of Ca2+ signalling at fertilization in mammals. Semin. Cell Dev. Biol., 12, 37-43.
48. Mitalipov, S.M., Nusser, K.D., and Wolf, D.P. (2001) Parthenogenetic activation of rhesus monkey oocytes and reconstructed embryos. Biol. Reprod., 65, 253-259.
49. Vrana, K.E., Hipp, J.D., Goss, A.M., McCool, B.A., Riddle, D.R., Walker, S.J., Wettstein, P.J., Studer, L.P., Tabar, V., Cunniff, K., Chapman, K., Vilner, L., West, M.D., Grant, K.A., and Cibelli, J.B. (2003) Nonhuman primate parthenogenetic stem cells. Proc. Natl. Acad. Sci. U. S. A, 100 Suppl 1, 11911-11916.
50. Cibelli, J.B., Grant, K.A., Chapman, K.B., Cunniff, K., Worst, T., Green, H.L., Walker, S.J., Gutin, P.H., Vilner, L., Tabar, V., Dominko, T., Kane, J., Wettstein, P.J., Lanza, R.P., Studer, L., Vrana, K.E., and West, M.D. (2002) Parthenogenetic stem cells in nonhuman primates. Science, 295, 819.
51. Paffoni, A., Brevini, T.A., Somigliana, E., Restelli, L., Gandolfi, F., and Ragni, G. (2006) In vitro development of human oocytes after parthenogenetic activation or intracytoplasmic sperm injection. Fertil. Steril..
52. Lanza, R.P., Cibelli, J.B., and West, M.D. (1999) Prospects for the use of nuclear transfer in human transplantation. Nat. Biotechnol., 17, 1171-1174.
53. Wakayama, T., Tabar, V., Rodriguez, I., Perry, A.C., Studer, L., and Mombaerts, P. (2001) Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science, 292, 740-743.
54. Solter, D. (2000) Mammalian cloning: advances and limitations. Nat. Rev. Genet., 1, 199-207.
55. Rideout, W.M., III, Eggan,K., and Jaenisch,R. (2001) Nuclear cloning and epigenetic reprogramming of the genome. Science, 293, 1093-1098.
56. Rideout, W.M., III, Hochedlinger, K., Kyba, M., Daley, G.Q., and Jaenisch, R. (2002) Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell, 109, 17-27.
57. Lanza, R.P., Cibelli, J.B., Blackwell, C., Cristofalo, V.J., Francis, M.K., Baerlocher, G.M., Mak, J., Schertzer, M., Chavez, E.A., Sawyer, N., Lansdorp, P.M., and West, M.D. (2000) Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science, 288, 665-669.
58. Tian, X.C., Xu, J., and Yang, X. (2000) Normal telomere lengths found in cloned cattle. Nat. Genet., 26, 272-273.
59. Wakayama, T., Shinkai, Y., Tamashiro, K.L., Niida, H., Blanchard, D.C., Blanchard, R.J., Ogura, A., Tanemura, K., Tachibana, M., Perry, A.C., Colgan, D.F., Mombaerts, P., and Yanagimachi, R. (2000) Cloning of mice to six generations. Nature, 407, 318-319.
60. Betts, D., Bordignon, V., Hill, J., Winger, Q., Westhusin, M., Smith, L., and King, W. (2001) Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle. Proc. Natl. Acad. Sci. USA, 98, 1077-1082.
61. Miyashita, N., Shiga, K., Yonai, M., Kaneyama, K., Kobayashi, S., Kojima, T., Goto, Y., Kishi, M., Aso, H., Suzuki, T., Sakaguchi, M., and Nagai, T. (2002) Remarkable differences in telomere lengths among cloned cattle derived from different cell types. Biol. Reprod., 66, 1649-1655.
62. Simerly, C., Dominko, T., Navara, C., Payne, C., Capuano, S., Gosman, G., Chong, K.Y., Takahashi, D., Chace, C., Compton, D., Hewitson, L., and Schatten, G. (2003) Molecular correlates of primate nuclear transfer failures. Science, 300, 297.
63. Booth, P.J., Viuff, D., Tan, S., Holm, P., Greve, T., and Callesen, H. (2003) Numerical chromosome errors in day 7 somatic nuclear transfer bovine blastocysts. Biol. Reprod., 68, 922-928.
64. Dean, W., Santos, F., Stojkovic, M., Zakhartchenko, V., Walter, J., Wolf, E., and Reik, W. (2001) Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos. Proc. Natl. Acad. Sci. USA, 98, 13734-13738.
65. Humpherys, D., Eggan, K., Akutsu, H., Hochedlinger, K., Rideout, W.M., III, Biniszkiewicz, D., Yanagimachi, R., and Jaenisch, R. (2001) Epigenetic instability in ES cells and cloned mice. Science, 293, 95-97.
66. Kang, Y.K., Koo, D.B., Park, J.S., Choi, Y.H., Chung, A.S., Lee, K.K., and Han, Y.M. (2001) Aberrant methylation of donor genome in cloned bovine embryos. Nat. Genet., 28, 173-177.
67. Humpherys, D., Eggan, K., Akutsu, H., Friedman, A., Hochedlinger, K., Yanagimachi, R., Lander, E.S., Golub, T.R., and Jaenisch, R. (2002) Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc. Natl. Acad. Sci. USA, 99, 12889-12894.
68. Kang, Y.K., Park, J.S., Koo, D.B., Choi, Y.H., Kim, S.U., Lee, K.K., and Han, Y.M. (2002) Limited demethylation leaves mosaic-type methylation states in cloned bovine pre-implantation embryos. EMBO J., 21, 1092-1100.
69. McGrath, J. and Solter, D. (1983) Nuclear transplantation in the mouse embryo by microsurgery and cell fusion. Science, 220, 1300-1302.
70. Willadsen, S.M. (1986) Nuclear transplantation in sheep embryos. Nature, 320, 63-65.
71. Prather, R.S., Barnes, F.L., Sims, M.M., Robl, J.M., Eyestone, W.H., and First, N.L. (1987) Nuclear transplantation in the bovine embryo: assessment of donor nuclei and recipient oocyte. Biol. Reprod., 37, 859-866.
72. Stice, S.L. and Robl, J.M. (1988) Nuclear reprogramming in nuclear transplant rabbit embryos. Biol. Reprod., 39, 657-664.
73. Prather, R.S., Sims, M.M., and First, N.L. (1989) Nuclear transplantation in early pig embryos. Biol. Reprod., 41, 414-418.
74. Campbell, K.H., McWhir, J., Ritchie, W.A., and Wilmut, I. (1996) Sheep cloned by nuclear transfer from a cultured cell line. Nature, 380, 64-66.
75. Hochedlinger, K. and Jaenisch, R. (2006) Nuclear reprogramming and pluripotency. Nature, 441, 1061-1067.
76. Rhind, S.M., Taylor, J.E., De Sousa, P.A., King, T.J., McGarry, M., and Wilmut, I. (2003) Human cloning: can it be made safe? Nat. Rev. Genet., 4, 855-864.
77. Rhind, S.M., King, T.J., Harkness, L.M., Bellamy, C., Wallace, W., DeSousa, P., and Wilmut, I. (2003) Cloned lambs - lessons from pathology. Nat. Biotechnol., 21, 744-745.
78. Hill, J.R., Roussel, A.J., Cibelli, J.B., Edwards, J.F., Hooper, N.L., Miller, M.W., Thompson, J.A., Looney, C.R., Westhusin, M.E., Robl, J.M., and Stice, S.L. (1999) Clinical and pathologic features of cloned transgenic calves and fetuses (13 case studies). Theriogenology, 51, 1451-1465.
79. Chavatte-Palmer, P., Heyman, Y., Richard, C., Monget, P., LeBourhis, D., Kann, G., Chilliard, Y., Vignon, X., and Renard, J.P. (2002) Clinical, hormonal, and hematologic characteristics of bovine calves derived from nuclei from somatic cells. Biol. Reprod., 66, 1596-1603.
80. Cibelli, J.B., Stice, S.L., Golueke, P.J., Kane, J.J., Jerry, J., Blackwell, C., Ponce de Leon, F.A., and Robl, J.M. (1998) Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science, 280, 1256-1258.
81. Ogonuki, N., Inoue, K., Yamamoto, Y., Noguchi, Y., Tanemura, K., Suzuki, O., Nakayama, H., Doi, K., Ohtomo, Y., Satoh, M., Nishida, A., and Ogura, A. (2002) Early death of mice cloned from somatic cells. Nat. Genet., 30, 253-254.
82. Hynes, M. and Rosenthal, A. (2000) Embryonic stem cells go dopaminergic. Neuron, 28, 11-14.
83. Svendsen, C.N. and Smith, A.G. (1999) New prospects for human stem-cell therapy in the nervous system. Trends Neurosci., 22, 357-364.
84. Bjorklund, L.M., Sanchez-Pernaute, R., Chung, S., Andersson, T., Chen, I.Y., McNaught, K.S., Brownell, A.L., Jenkins, B.G., Wahlestedt, C., Kim, K.S., and Isacson, O. (2002) Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad Sci. USA, 99, 2344-2349.
85. Rezzani, R. (2004) Cyclosporine A and adverse effects on organs: histochemical studies. Prog. Histochem. Cytochem., 39, 85-128.
86. Dawson, L., Bateman-House, A.S., Mueller, A.D., Bok, H., Brock, D.W., Chakravarti, A., Greene, M., King, P.A., O'Brien, S.J., Sachs, D.H., Schill, K.E., Siegel, A., Solter, D., Suter, S.M., Verfaillie, C.M., Walters, L.B., Gearhart, J.D., and Faden, R.R. (2003) Safety issues in cell-based intervention trials. Fertil. Steril., 80, 1077-1085.
87. Gruen, L. and Grabel, L. (2006) Concise review: scientific and ethical roadblocks to human embryonic stem cell therapy. Stem Cells, 24, 2162-2169.
88. Martin, M.J., Muotri, A., Gage, F., and Varki, A. (2005) Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med., 11, 228-232.
89. Genbacev, O., Krtolica, A., Zdravkovic, T., Brunette, E., Powell, S., Nath, A., Caceres, E., McMaster, M., McDonagh, S., Li, Y., Mandalam, R., Lebkowski, J., and Fisher, S.J. (2005) Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil. Steril., 83, 1517-1529.
90. Inzunza, J., Gertow, K., Stromberg, M.A., Matilainen, E., Blennow, E., Skottman, H., Wolbank, S., Ahrlund-Richter, L., and Hovatta, O. (2005) Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells, 23, 544-549.
91. Simon, C., Escobedo, C., Valbuena, D., Genbacev, O., Galan, A., Krtolica, A., Asensi, A., Sanchez, E., Esplugues, J., Fisher, S., and Pellicer, A. (2005) First derivation in Spain of human embryonic stem cell lines: use of long-term cryopreserved embryos and animal-free conditions. Fertil. Steril., 83, 246-249.
92. Lee, J.B., Lee, J.E., Park, J.H., Kim, S.J., Kim, M.K., Roh, S.I., and Yoon, H.S. (2005) Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol. Reprod., 72, 42-49.
93. Cheng, L., Hammond, H., Ye, Z., Zhan, X., and Dravid, G. (2003) Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells, 21, 131-142.
94. Beattie, G.M., Lopez, A.D., Bucay, N., Hinton, A., Firpo, M.T., King, C.C., and Hayek, A. (2005) Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells, 23, 489-495.
95. Amit, M., Shariki, C., Margulets, V., and Itskovitz-Eldor, J. (2004) Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod., 70, 837-845.
96. Kallos, M.S., Behie, L.A., and Vescovi, A.L. (1999) Extended serial passaging of mammalian neural stem cells in suspension bioreactors. Biotechnol. Bioeng., 65, 589-599.
97. Sen, A., Kallos, M.S., and Behie, L.A. (2002) Passaging protocols for mammalian neural stem cells in suspension bioreactors. Biotechnol. Prog., 18, 337-345.
98. Sen, A., Kallos, M.S., and Behie, L.A. (2004) New tissue dissociation protocol for scaled-up production of neural stem cells in suspension bioreactors. Tissue Eng, 10, 904-913.
99. Draper, J.S., Smith, K., Gokhale, P., Moore, H.D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T.P., Thomson, J.A., and Andrews, P.W. (2004) Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol., 22, 53-54.
100. Inzunza, J., Sahlen, S., Holmberg, K., Stromberg, A.M., Teerijoki, H., Blennow, E., Hovatta, O., and Malmgren, H. (2004) Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol. Hum. Reprod., 10, 461-466.
101. Roy, N.S., Cleren, C., Singh, S.K., Yang, L., Beal, M.F., and Goldman, S.A. (2006) Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med., 12, 1259-1268.
102. Lee, S.H., Lumelsky, N., Studer, L., Auerbach, J.M., and McKay, R.D. (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol., 18, 675-679.
103. Kim, J.H., Auerbach, J.M., Rodriguez-Gomez, J.A., Velasco, I., Gavin, D., Lumelsky, N., Lee, S.H., Nguyen, J., Sanchez-Pernaute, R., Bankiewicz, K., and McKay, R. (2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature, 418, 50-56.
104. Master, Z., McLeod, M., and Mendez, I. (2007) Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease. Journal of Medical Ethics, In Press.
105. Glass, K.C., Weijer, C., Cournoyer, D., Lemmens, T., Palmour, R.M., Shapiro, S.H., and Freedman, B. (1999) Structuring the review of human genetics protocols, part III: gene therapy studies. IRB., 21, 1-9.
106. Modo, M., Mellodew, K., Cash, D., Fraser, S.E., Meade, T.J., Price, J., and Williams, S.C. (2004) Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage., 21, 311-317.
107. Rathjen, P.D., Lake, J., Whyatt, L.M., Bettess, M.D., and Rathjen, J. (1998) Properties and uses of embryonic stem cells: prospects for application to human biology and gene therapy. Reprod. Fertil. Dev., 10, 31-47.
108. Dinsmore, J., Ratliff, J., Jacoby, D., Wunderlich, M., and Lindberg,C. (1998) Embryonic stem cells as a model for studying regulation of cellular differentiation. Theriogenology, 49, 145-151.
109. Dani, C. (1999) Embryonic stem cell-derived adipogenesis. Cells Tissues. Organs, 165, 173-180.
110. Schuldiner, M., Yanuka,O., Itskovitz-Eldor,J., Melton, D.A., and Benvenisty, N. (2000) Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 97, 11307-11312.
111. Sperger, J.M., Chen, X., Draper, J.S., Antosiewicz, J.E., Chon, C.H., Jones, S.B., Brooks, J.D., Andrews, P.W., Brown, P.O., and Thomson, J.A. (2003) Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA, 100, 13350-13355.
112. D'Amour, K.A. and Gage, F.H. (2003) Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells. Proc. Natl. Acad. Sci. USA, 100 Suppl 1, 11866-11872.
113. Araki, R., Fukumura, R., Sasaki, N., Kasama, Y., Suzuki, N., Takahashi, H., Tabata, Y., Saito, T., and Abe, M. (2006) More than 40,000 transcripts, including novel and noncoding transcripts, in mouse embryonic stem cells. Stem Cells, 24, 2522-2528.
114. Zeng, X., Miura, T., Luo, Y., Bhattacharya, B., Condie, B., Chen, J., Ginis, I., Lyons, I., Mejido, J., Puri, R.K., Rao, M.S., and Freed, W.J. (2004) Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells, 22, 292-312.
115. Richards, M., Tan, S.P., Tan, J.H., Chan, W.K., and Bongso, A. (2004) The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells, 22, 51-64.
116. D'Amour, K.A., Agulnick, A.D., Eliazer, S., Kelly, O.G., Kroon, E., and Baetge, E.E. (2005) Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol., 23, 1534-1541.
117. Hubner, K., Fuhrmann, G., Christenson, L.K., Kehler, J., Reinbold, R., De La, F.R., Wood, J., Strauss, J.F., III, Boiani, M., and Scholer, H.R. (2003) Derivation of oocytes from mouse embryonic stem cells. Science, 300, 1251-1256.
118. Toyooka, Y., Tsunekawa, N., Akasu, R., and Noce, T. (2003) Embryonic stem cells can form germ cells in vitro. Proc. Natl. Acad. Sci. USA, 100, 11457-11462.
119. Geijsen, N., Horoschak, M., Kim, K., Gribnau, J., Eggan, K., and Daley, G.Q. (2004) Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature, 427, 148-154.
120. West, J.A. and Daley, G.Q. (2004) In vitro gametogenesis from embryonic stem cells. Curr. Opin. Cell Biol., 16, 688-692.
121. Master, Z. (2006) Embryonic stem-cell gametes: the new frontier in human reproduction. Hum. Reprod., 21, 857-863.
122. Jones, K.W., Singh, L., and Edwards, R.G. (1987) The use of probes for the Y chromosome in preimplantation embryo cells. Hum. Reprod., 2, 439-445.
123. Handyside, A.H., Kontogianni, E.H., Hardy, K., and Winston, R.M. (1990) Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature, 344, 768-770.
124. Verlinsky, Y., Strelchenko, N., Kukharenko, V., Rechitsky, S., Verlinsky, O., Galat, V., and Kuliev, A. (2005) Human embryonic stem cell lines with genetic disorders. Reprod. Biomed. Online., 10, 105-110.
125. Pickering, S.J., Minger, S.L., Patel, M., Taylor, H., Black, C., Burns, C.J., Ekonomou, A., and Braude, P.R. (2005) Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using premiplantation genetic diagnosis. Reprod. Biomed. Online., 10, 390-397.
126. Verlinsky, Y. and Kuliev, A. (2003) Current status of preimplantation diagnosis for single gene disorders. Reprod. Biomed. Online., 7, 145-150.
127. Verlinsky, Y. (2005) Designing babies: what the future holds. Reprod. Biomed. Online., 10 Suppl 1, 24-26.
128. Mimeault, M. and Batra, S.K. (2006) Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells, 24, 2319-2345.
129. Chambers, I. and Smith, A. (2004) Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene, 23, 7150-7160.
130. Andrews, P.W., Matin, M.M., Bahrami, A.R., Damjanov, I., Gokhale, P., and Draper, J.S. (2005) Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans., 33, 1526-1530.
131. Kim, C.F., Jackson, E.L., Woolfenden, A.E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R.T., and Jacks, T. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121, 823-835.
132. Fang, D., Nguyen, T.K., Leishear, K., Finko, R., Kulp, A.N., Hotz, S., Van Belle, P.A., Xu, X., Elder, D.E., and Herlyn, M. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res., 65, 9328-9337.
133. Piersma, A.H. (2004) Validation of alternative methods for developmental toxicity testing. Toxicol. Lett., 149, 147-153.
134. zur Nieden, N.I., Kempka, G., and Ahr, H.J. (2004) Molecular multiple endpoint embryonic stem cell test - a possible approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol., 194, 257-269.
135. Jasanoff, S. (2005) Designs on nature. Princeton University Press, New Jersey.
136. Marquis, D. (2002) An argument that abortion is wrong. In Morality and Moral Controversies. Readings in Moral, Social and Political Philosophy (Arthur,J., ed), pp. 218-227. Prentice Hall, New Jersey.
137. Roe v. Wade (2002) The constitutional right to abortion. In Morality and Moral Controversies. Readings in Moral, Social, and Political Philosophy (Arthur, J., ed), pp. 190-195. Prentice Hall, New Jersey.
138. Warren, M. (2002) On the moral and legal status of abortion. In Morality and Moral Controversies. Readings in Moral, Social and Political Philosophy (Arthur, J., ed), pp. 204-210. Prentice Hall, New Jersey.
139. English, J. (1975) Abortion and the concept of a person. Can. J. Philos., 5, 233-243.
140. United Nations. Universal Declaration of Human Rights. General Assembly resolution 217A (III). 1948. Unenacted Bill/Resolution.
141. Bortolotti, L. and Harris, J. (2005) Stem cell research, personhood and sentience. Reprod. Biomed. Online., 10 (Suppl 1), 68-75.
142. Kittay, E.F. (2005) At the margins of moral personhood. Ethics, 116, 100-131.
143. Green, R.M. (2002) Stem cell research: a target article collection: Part III - determining moral status. Am. J. Bioeth., 2, 20-30.
144. Nagashima, H., Matsui, K., Sawasaki, T., and Kano, Y. (1984) Production of monozygotic mouse twins from microsurgically bisected morulae. J. Reprod. Fertil., 70, 357-362.
145. Williams, T.J., Elsden, R.P., and Seidel, G.E., Jr. (1984) Pregnancy rates with bisected bovine embryos. Theriogenology, 22, 521-531.
146. Nagashima, H., Kato, Y., and Ogawa, S. (1989) Microsurgical bisection of porcine morulae and blastocysts to produce monozygotic twin pregnancy. Gamete Res., 23, 1-9.
147. American Medical Association. Pre-Embryo Splitting. 2007. E-2.145. Unenacted Bill/Resolution.
148. Bill C-6 (Royal Assent). (2004) An Act Respecting Assisted Human Reproduction and Related Research (Assisted Human Reproduction Act). Third Session, Thirty-seventh Parliament. http://www.parl.gc.ca/PDF/37/3/ parlbus/chambus/house/bills/government/C-6_4.pdf.
149. Thomson, J.J. (1971) A defense of abortion. Philosophy and Public Affairs, 1, 47-66.
150. Copland, P. and Gillett, G. (2003) The bioethical structure of a human being. J. Appl. Philos., 20, 123-131.
151. Steinbock, B. (2001) Respect for human embryos. In Cloning and the Future of Human Embryo Research (Lauritzen, P., ed), pp. 21-33. Oxford University Press, New York.
152. Steinbock, B. (1992) Life before birth the moral and legal status of embryos and fetuses. Oxford University Press, New York.
153. Robertson, J.A. (1995) Symbolic issues in embryo research. Hastings Cent. Rep., 25, 37-38.
154. Ryan, M.A. (2001) Creating embryos for research: on weighing symbolic costs. In Cloning and the Future of Human Embryo Research (Lauritzen,P., ed), pp. 50-66. Oxford University Press, New York.
155. Waller, L. (1987) Reproductive technology: in Australia, the debate moves to embryo experimentation. Hastings Cent. Rep., 17, S21-S22.
156. Krimsky, S. and Hubbard, R. (1995) The business of research. Hastings Cent. Rep., 25, 41-43.
157. Sullivan, L. (1993) In the path of Daedalus: middle-class Australians' attitudes to embryo research. Br. J. Sociol., 44, 271-302.
158. Budev, M.M., Arroliga, A.C., and Falcone, T. (2005) Ovarian hyperstimulation syndrome. Crit Care Med., 33, S301-S306.
159. Delvigne, A. and Rozenberg, S. (2003) Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum. Reprod. Update., 9, 77-96.
160. Golan, A., Ron-el, R, Herman, A., Soffer, Y., Weinraub, Z., and Caspi, E. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv., 44, 430-440.
161. Mathur, R.S., Akande, A.V., Keay, S.D., Hunt, L.P., and Jenkins, J.M. (2000) Distinction between early and late ovarian hyperstimulation syndrome. Fertil. Steril., 73, 901-907.
162. Rizk, B. and Aboulghar, M. (2005) Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In Textbook of In Vitro Fertilization and Assisted Reproduction. The Bourn Hall Guide to Clinical and Laboratory Practice (Brisden,P.R., ed), pp. 217-258. Taylor and Francis Group, New York.
163. (2004) Ovarian hyperstimulation syndrome. Fertil. Steril., 82 Suppl 1, S81-S86.
164. Wakeley, K.E. and Grendys, E.C. (2000) Reproductive technologies and risk of ovarian cancer. Curr. Opin. Obstet. Gynecol., 12, 43-47.
165. Ness, R.B., Cramer, D.W., Goodman, M.T., Kjaer, S.K., Mallin, K., Mosgaard, B.J., Purdie, D.M., Risch, H.A., Vergona, R., and Wu, A.H. (2002) Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am. J. Epidemiol., 155, 217-224.
166. Rossing, M.A., Daling, J.R., Weiss, N.S., Moore, D.E., and Self, S.G. (1994) Ovarian tumors in a cohort of infertile women. N. Engl. J. Med., 331, 771-776.
167. Shushan, A., Paltiel, O., Iscovich, J., Elchalal, U., Peretz, T., and Schenker, J.G. (1996) Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil. Steril., 65, 13-18.
168. Venn, A., Watson, L., Lumley, J., Giles, G., King, C., and Healy, D. (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet, 346, 995-1000.
169. Althuis, M.D., Moghissi, K.S., Westhoff, C.L., Scoccia, B., Lamb, E.J., Lubin, J.H., and Brinton, L.A. (2005) Uterine cancer after use of clomiphene citrate to induce ovulation. Am. J. Epidemiol., 161, 607-615.
170. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., Kotchen, J.M., and Ockene, J. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
171. Wassertheil-Smoller, S., Hendrix, S.L., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J.D., Black, H., Rossouw, J.E., Aragaki, A., Safford, M., Stein, E., Laowattana, S., and Mysiw, W.J. (2003) Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA, 289, 2673-2684.
172. Manson, J.E., Hsia, J., Johnson, K.C., Rossouw, J.E., Assaf, A.R., Lasser, N.L., Trevisan, M., Black, H.R., Heckbert, S.R., Detrano, R., Strickland, O.L., Wong, N.D., Crouse, J.R., Stein, E., and Cushman, M. (2003) Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med., 349, 523-534.
173. Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K., Hendrix, S.L., Jones, B.N., III, Assaf, A.R., Jackson, R.D., Kotchen, J.M., Wassertheil-Smoller, S., and Wactawski-Wende, J. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA, 289, 2651-2662.
174. Beeson, D. and Lippman, A. (2006) Egg harvesting for stem cell research: medical risks and ethical problems. Reprod. Biomed. Online., 13, 573-579.
175. Ludwig, A.K., Glawatz, M., Griesinger, G., Diedrich, K., and Ludwig, M. (2006) Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum. Reprod., 21, 3235-3240.
176. Gabriel, T. High-Tech Pregnancies Test Hope's Limit. The New York Times Late Edition - Final, Section 1, Page 1, Column 1. 1999. New York, NY, The New York Times Company.
177. Padawer, R. Soaring egg donation prices causing ethical concerns. http://www.gettingpregnantbook.com/EggDonationCostsSoar.htm. 2002.
178. Steinbock, B. (2004) Payment for egg donation and surrogacy. Mt. Sinai J. Med., 71, 255-265.
179. The Ethics Committee of the American Society for Reproductive Medicine. (2000) Financial incentives in recruitment of oocyte donors. Fertil. Steril., 74, 216-220.
180. Hirschman, E.C. (1991) Babies for sale: market ethics and the new reproductive technologies. J. Consum. Aff., 25, 358-390.
181. Macklin, R. (2003) What is wrong with Commodification. In Ethical Issues in Modern Medicine (Steinbock,B., Arras,J.D., and London,A., eds), pp. 615-624. McGraw-Hill, New York.
182. Corrigan, O. (2003) Empty ethics: the problem with informed consent. Sociol. Health Illn., 25, 768-792.
183. Gurmankin, A.D. (2001) Risk information provided to prospective oocyte donors in a preliminary phone call. Am. J. Bioeth., 1, 3-13.
184. (2004) Informed consent and the use of gametes and embryos for research. Fertil. Steril., 82 (Suppl 1), S251-S252.
185. Newton, C.R., McDermid, A., Tekpetey, F., and Tummon, I.S. (2003) Embryo donation: attitudes toward donation procedures and factors predicting willingness to donate. Hum. Reprod., 18, 878-884.
186. Nachtigall, R.D., Becker, G., Friese, C., Butler, A., and MacDougall, K. (2005) Parents' conceptualization of their frozen embryos complicates the disposition decision. Fertil. Steril., 84, 431-434.
187. Appelbaum, P.S., Roth, L.H., Lidz, C.W., Benson, P., and Winslade, W. (1987) False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent. Rep., 17, 20-24.
188. Magnus, D. and Cho, M.K. (2005) Ethics. Issues in oocyte donation for stem cell research. Science, 308, 1747-1748.
189. (2002) Donating spare embryos for embryonic stem-cell research. Fertil. Steril., 78, 957-960.
190. Chung, Y., Klimanskaya, I., Becker, S., Marh, J., Lu, S.J., Johnson, J., Meisner, L., and Lanza, R. (2006) Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature, 439, 216-219.
191. Klimanskaya, I., Chung, Y., Becker, S., Lu, S.J., and Lanza, R. (2006) Human embryonic stem cell lines derived from single blastomeres. Nature, 444, 481-485.
192. Nisker, J. and White, A. (2005) The CMA Code of Ethics and the donation of fresh embryos for stem cell research. CMAJ., 173, 621-622.
193. Lewis, R. (2006) Blastomere blasphemy. Am. J. Bioeth., 6, 1-3.
194. Pearson, H. (2006) Early embryos can yield stem cells... and survive. Nature, 442, 858.
195. Liao, S.M. (2005) Rescuing human embryonic stem cell research: the Blastocyst Transfer Method. Am. J. Bioeth., 5, 8-16.
196. Master, Z. (2005) Can we really bypass the moral debate for embryo research? Am. J. Bioeth., 5, 27-28.
197. Newton, C.R., McBride, J., Feyles, V., Tekpetey, F., and Power, S. (2006) Factors affecting patients' attitudes toward single- and multiple-embryo transfer. Fertil. Steril..
198. Child, T.J., Henderson, A.M., and Tan, S.L. (2004) The desire for multiple pregnancy in male and female infertility patients. Hum. Reprod., 19, 558-561.
199. President's Council on Bioethics. (2005) Alternative sources of human pluripotent stem cells. A white paper. 1-99.
200. Lyle, R. (1997) Gametic imprinting in development and disease. J. Endocrinol., 155, 1-12.
201. Marchant, J. (2006) Human eggs supply 'ethical' stem cells. Nature, 441, 1038.
202. Kiessling, A.A. (2005) Eggs alone. Nature, 434, 145.
203. Fangerau, H. (2005) Can artificial parthenogenesis sidestep ethical pitfalls in human therapeutic cloning? An historical perspective. J. Med. Ethics, 31, 733-735.
204. Kim, K., Lerou, P., Yabuuchi, A., Lengerke, C., Ng, K., West, J., Kirby, A., Daly, M.J., and Daley, G.Q. (2006) Histocompatible Embryonic Stem Cells by Parthenogenesis. Science.
205. Hurlbut, W.B. (2005) Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. Perspect. Biol. Med., 48, 211-228.
206. Meissner, A. and Jaenisch, R. (2006) Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature, 439, 212-215.
207. Chawengsaksophak, K., de Graaff, W., Rossant, J., Deschamps, J., and Beck, F. (2004) Cdx2 is essential for axial elongation in mouse development. Proc. Natl. Acad. Sci. USA, 101, 7641-7645.
208. Strumpf, D., Mao, C.A., Yamanaka, Y., Ralston, A., Chawengsaksophak, K., Beck, F., and Rossant, J. (2005) Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst. Development, 132, 2093-2102.
209. Jones, N.L. and Cheshire, W.P. (2005) Can artificial techniques supply morally neutral human embryos for research? Part I. Creating novel categories of human embryos. Ethics Med., 21, 29-40.
210. Cheshire, W.P. and Jones, N.L. (2005) Can artificial techniques supply morally neutral human embryos for research? Ethics Med., 21, 73-88.
211. Atkinson-Grosjean, J. (2006) Public science private interests: culture and commerce in Canada's Networks of Centres of Excellence. University of Toronto Press, Toronto.
212. Nelkin, D. and Andrews, L.B. (1998) Homo economicus: commercialization of body tissue in the age of biotechnology. Hastings Center Report, 28, 30-39.
213. Annas, G.J. (1988) Whose waste is it anyway? The case of John Moore. Hastings Cent. Rep., 18, 37-39.
214. Isasi, R.M. and Knoppers, B.M. (2006) Mind the gap: policy approaches to embryonic stem cell and cloning research in 50 countries. Eur. J. Health Law, 13, 9-25.
215. Knowles, L.P. (2004) A regulatory patchwork - human ES cell research oversight. Nat. Biotechnol., 22, 157-163.
216. Glasner, P. (2005) Banking on Immortality? Exploring the Stem Cell Supply Chain from Embryo to Therapeutic Application. Current Sociology, 53, 355-366.
217. Fischbach, G.D. and Fischbach, R.L. (2004) Stem cells: science, policy, and ethics. J. Clin. Invest, 114, 1364-1370.
218. Russo, E. (2005) Follow the money - the politics of embryonic stem cell research. PLoS. Biol., 3, e234.
219. Dickenson, D. (2002) Commodification of human tissue: implications for feminist and development ethics. Developing. World Bioeth., 2, 55-63.
220. Jain, K.K. (2005) Ethical and regulatory aspects of embryonic stem cell research. Expert. Opin. Biol. Ther., 5, 153-162.
221. de Wert, G. and Mummery, C. (2003) Human embryonic stem cells: research, ethics and policy. Hum. Reprod., 18, 672-682.
222. Harris, J. (2003) Stem cells, sex, and procreation. Camb. Q. Healthc. Ethics, 12, 353-371.
223. Santos, G.A. and Doty, M.S. (1975) IR studies on carrageenan of Ahnfeltia concinna, a marine red alga. J. Pharm. Sci., 64, 1704-1706.
224. Mahoney, J.D. (2000) The market for human tissue. Va. Law Rev., 86, 163-223.
225. Titmuss, R.M. (1971) The gift relationship: from human blood to social policy. Pantheon Books, New York.
226. Sullivan, P. (2005) Developing an administrative plan for transfusion medicine - a global perspective. Transfusion, 45, 224S-240S.
227. Lock, M. (2002) Human body parts as therapeutic tools: contradictory discourses and transformed subjectivities. Qual. Health Res., 12, 1406-1418.
228. Radin, M.J. (1982) Property and personhood. Stanford Law Review, 34, 957-1015.
229. Radin, M.J. (1987) Market-inalienability. Harvard Law Review, 100, 1849-1937.
230. Bray, M.B. (1990) Personalizing personality: toward a property right in human bodies. Tex. Law Rev., 69, 209-244.
231. Waldby, C. (2002) Stem Cells, Tissue Cultures and the Production of Biovalue. Health, 6, 305-323.
232. Magnus, D., Caplun, A., and McGee, G. (2002) Who owns life? Prometheus Books, Amherst.
233. Gilmour, J.M. (1993) Our bodies: property rights in human tissue. Canadian Journal of Law and Society, 8, 113-138.
234. Bjorkman, B. and Hansson, S.O. (2006) Bodily rights and property rights. J. Med. Ethics, 32, 209-214.
235. Dickenson, D. (2006) The lady vanishes: what's missing from the stem cell debate. Journal of Bioethical Inquiry, 3, 43-54.
236. Kevles, D. (1998) Diamond v. Chakrabarty and beyond: the political economy of patenting life. In Private Science: Biotechnology and the Rise of the Molecular Sciences (Thackray,A., ed), pp. 65-79. University of Pennsylvania Press, Pittsburgh.
237. Caulfield, T.A. and Gold, E.R. (2000) Whistling in the wind: patents on genetic research ara a reality. It's time to reframe the debate. Form for Applied Research and Public Policy, Spring, 75-79.
238. Knowles, L.P. (2003) Of mice and men: patenting the oncomouse. Hastings Cent. Rep., 33, 6-7.
239. Resnik, D.B. (2002) The commercialization of human stem cells: ethical and policy issues. Health Care Anal., 10, 127-154.
240. Loring, J.F. and Campbell, C. (2006) Science and law. Intellectual property and human embryonic stem cell research. Science, 311, 1716-1717.
241. Taymor, K.S., Scott, C.T., and Greely, H.T. (2006) The paths around stem cell intellectual property. Nat. Biotechnol., 24, 411-413.
242. Patent Act. P-4. 1985. Ref Type: Bill/Resolution
243. Siegel, A.W. (2004) Temporal restrictions and the impasse on human embryonic stem-cell research. Lancet, 364, 215-218.
244. Rabin, S. (2005) The gatekeepers of hES cell products. Nat. Biotechnol., 23, 817-819.
245. Caulfield, T. (2006) Stem Cell Patents and Social Controversy: A Speculative View from Canada. Medical Law International, 7, 219-232.
246. Herder, M. (2006) Proliferating patent problems with human embryonic stem cell research. Journal of Bioethical Inquiry, 3, 69-79.
247. Williams-Jones, B. and Corrigan, O.P. (2003) Rhetoric and hype: where's the 'ethics' in pharmacogenomics? Am. J. Pharmacogenomics., 3, 375-383.
248. Normile, D. and Mann, C.C. (2005) Cell biology. Asia jockeys for stem cell lead. Science, 307, 660-664.
249. De Trizio, E. and Brennan, C.S. (2004) The business of human embryonic stem cell research and an international analysis of relevant laws. J. Biolaw. Bus., 7, 14-22.
250. Hyun, I. (2006) Magic eggs and the frontier of stem cell science. Hastings Cent. Rep., 36, 16-19.
251. MacDonald, C. (2002) Stem cell ethics and the forgotten corporate context. Am. J. Bioeth., 2, 54-56.
252. Giebel, L.B. (2005) Stem cells - a hard sell to investors. Nat. Biotechnol., 23, 798-800.
253. Little, M., Hall, W., and Orlandi, A. (2006) Delivering on the promise of human stem-cell research. What are the real barriers? EMBO Rep., 7, 1188-1192.